Division of Infectious Diseases and Immunology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuou-ku, Saitama-shi, Saitama, 330-8777, Japan.
Department of Paediatrics, The University of Tokyo, Tokyo, Japan.
BMC Pediatr. 2018 Nov 23;18(1):369. doi: 10.1186/s12887-018-1348-8.
Congenital cytomegalovirus (cCMV) infection leads to sensorineural hearing loss (SNHL) and neurodevelopmental delays. However, the long-term outcomes of cCMV infection with severe neurological manifestations in infancy remain unclear.
The patient was a one-month-old girl visited owing to abnormalities in neonatal hearing screening. Central nervous system involvement including intracranial calcification and extensive white matter abnormalities was identified. Right SNHL (50 dB) was detected by auditory brain response (ABR) testing. The cause of her hearing loss was determined to be cCMV infection by polymerase chain reaction (PCR) using a dried blood spot. At 1.5 months of age, the patient was treated with intravenous ganciclovir (GCV) for 5 weeks followed by oral valganciclovir (VGCV) for an additional 6 weeks. Cytomegalovirus (CMV) loads in her urine continued to be detected until she was 10 years old. Fortunately, during this time, her right hearing loss did not deteriorate, and her left hearing remained normal. Furthermore, the extensive abnormal areas of white matter observed at 1 month of age mostly disappeared by the time the patient was 9 years old. Her neurodevelopmental score was normal, and motor milestones were not delayed as of 10 years of age.
Here, we report the 10-year follow-up of a patient with cCMV who showed normal neurodevelopment, no progression of hearing loss, and ameliorating magnetic resonance imaging (MRI) findings, despite having various complications and severe neurological findings during infancy.
先天性巨细胞病毒(cCMV)感染可导致感音神经性听力损失(SNHL)和神经发育迟缓。然而,婴儿期有严重神经表现的 cCMV 感染的长期结局仍不清楚。
患儿因新生儿听力筛查异常就诊,存在中枢神经系统受累,包括颅内钙化和广泛的白质异常。通过听性脑干反应(ABR)测试发现右 SNHL(50dB)。聚合酶链反应(PCR)检测发现患儿因 cCMV 感染导致听力损失,通过干血斑检测。患儿在 1.5 个月时接受静脉用更昔洛韦(GCV)治疗 5 周,随后口服缬更昔洛韦(VGCV)治疗 6 周。患儿尿液中的巨细胞病毒(CMV)载量持续检测至 10 岁。幸运的是,在此期间,她的右耳听力未恶化,左耳听力正常。此外,1 月龄时观察到的广泛白质异常区域在患儿 9 岁时大部分消失。其神经发育评分正常,运动发育里程碑在 10 岁时尚未延迟。
本研究报道了 1 例 cCMV 患儿的 10 年随访情况,尽管患儿在婴儿期存在多种并发症和严重的神经表现,但神经发育正常,听力损失无进展,磁共振成像(MRI)结果改善。